Article Text

other Versions

PDF

Does Helicobacter pylori infection modify lung development, height or simply reflect shared environmental exposures?
  1. Andrew W Fogarty
  1. Correspondence to Dr Andrew W Fogarty, Division of Epidemiology and Public Health, University of Nottingham, Nottingham City Hospital, Nottingham NG5 1PB, UK; andrew.fogarty{at}nottingham.ac.uk

Statistics from Altmetric.com

The identification of Helicobacter pylori as a pathogen associated with gastric disease has led to serological assays that can establish exposure in larger study populations and hence exploration of associations with diseases epidemiologically. The paper by Sze et al,1 is an elegant example of this process. The authors have used the data from the Lung Health Study, which is a large prospective cohort based on a randomised trial of a smoking cessation intervention coupled with an ipratropium inhaler2 that evaluated data on 4765 patients with mild to moderate COPD at baseline, who were followed up for 11 years. The ascertainment of H. pylori status was made serologically after 5 years of follow-up, and then cross-sectional associations and longitudinal changes in lung function over 11 years were examined stratified by H. pylori status. The results are that absolute lung function is lower in individuals with evidence of exposure to H. pylori infection, but that per cent predicted lung function is not. This difference is accounted for by height which is a component of per cent predicted lung function, as those individuals with H. pylori positive serology were shorter than those who were not. Interestingly, exposure to H. pylori infection was also associated with higher systemic inflammation (as measured by C reactive protein) cross-sectionally, and lower educational attainment. The latter is considered a measure of socioeconomic status in childhood, suggesting that early life environment may be important. There was no association between H. pylori status and rate of decline of lung function, which suggests that this is not a modifiable risk factor that can be considered for lung preservation strategies in this population. Finally, there was an excess mortality from cardiovascular mortality in the patients who were seropositive for H. pylori, although it is not clear if this analysis was adjusted for age (the mean age of the H. pylori positive group was almost 2 years older than the H. pylori negative group).

These observations are generally similar to those from our population-based study of 2361 individuals from Nottingham, UK, where evidence of H. pylori serological exposure was associated with lower lung function, again as a consequence of smaller stature,3 and H. pylori exposure was also associated with lower measures of socioeconomic status and increased systemic inflammation.4

There are two questions for epidemiologists with regards to the interpretation of observational data. ‘Is this a causal effect?’ and ‘is it important?’ H. pylori appears to be associated with smaller stature, and hence smaller lungs. Demonstrating that H. pylori infection is the casual agent that impairs lung development to the level of proof needed to support intervention is a challenging prospect. Future areas of research could consider measuring H. pylori status in child development cohorts that include measures of lung function and have access to multiple measurements of H. pylori status from early life onwards. However, this issue is complicated by the fact that some children can change from seropositivity back to a seronegative status. In a population-based birth cohort in Ethiopia, 17% of children who had evidence of H. pylori infection using a faecal antigen assay at age 3 years, ceased to be positive at the age of 5 years.5 The issue of fluctuating exposure status is a big challenge for the study of the impact of H. pylori infection on children's health and development.

While the prevalence of H. pylori infection was 18% in the study by Sze et al, there is a strong cohort effect, with birth cohorts from recent decades having a markedly lower prevalence of infection in the UK than those born before the 1960s.3 Hence, even if this is a true association, the relative importance is decreasing in developed countries like the UK at least. In addition, as populations develop economically, better nutrition and healthcare in early life is associated with an increase in height and presumably lung function. In societies where exposure to environmental insults such as tobacco smoke and other forms of air pollution from conception onwards decreases, lung function can be expected to improve for those who are young enough to benefit from these changes. Hence, even if there is a causal association between H. pylori infection and growth, the relative importance of this compared with other factors that modify growth and lung development can be expected to decrease for children born in recent years.

Acknowledgments

The author thanks John Britton for comments on the manuscript.

References

View Abstract

Footnotes

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Chronic obstructive pulmonary disease
    Marc A Sze Yu-Wei Roy Chen Sheena Tam Donald Tashkin Robert A Wise John E Connett SF Paul Man Don D Sin
  • Airwaves
    Nicholas Hart Gisli Jenkins Alan Smyth